29 Results for "

rat striatum

" in MedChemExpress (MCE) Product Catalog:
Products (29)

29 Results for "rat striatum" in MCE Product Catalog:

8
8 Cited Publications
Cat. No.: HY-14197A
CAS No.: 17780-75-5
Purity:  99.92%
Target:  

Monoamine Oxidase

Research Areas:  

Metabolic Disease

Clorgyline hydrochloride is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research, structurally related to Pargyline (HY-A0091A). Clorgyline hydrochloride has little effect on the amounts of conjugated dopamine (DA) present in superfusate of slices from rat striatum. Clorgyline hydrochloride contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-A0151
CAS No.: 316-81-4
Synonyms: RP 7843; SKF 5883; Thioperazine
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12363
CAS No.: 96744-75-1
Purity:  99.73%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

U-69593 is a potent and selective κ1-opioid receptor agonist . U-69593 attenuates addictive agent-induced behavioral sensitization in the rat . U-69593 reduces anxiety and enhances spontaneous alternation memory in mice . U-69593 reduces calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum .
loading...
    loading...
Cat. No.: HY-145512
CAS No.: 259143-19-6
Synonyms: NLT
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

N-(α-Linolenoyl) tyrosine (NLT) is a dopaminergic agonist capable of crossing the blood-brain barrier. N-(α-Linolenoyl) tyrosine increases the level, turnover rate and release amount of dopamine in the striatum. N-(α-Linolenoyl) tyrosine modulates rotational behavior in a rat model with unilateral striatal injury and alleviates excessive blinking symptoms in models induced by dopamine-depleting agents. N-(α-Linolenoyl) tyrosine can be used for research on Parkinson's disease and idiopathic blepharospasm .
loading...
    loading...
Cat. No.: HY-P99157
CAS No.: 1895083-75-6
Synonyms: Mab 8H9
Target:  

CD276/B7-H3

Research Areas:  

Neurological Disease Cancer

Omburtamab (Mab 8H9) is a mouse monoclonal immunoglobulin G1 (IgG1) antibody targeting B7-H3. Omburtamab specifically binds to the glycoprotein antigen B7-H3, which is widely expressed on the surface of tumor cells. As a targeting carrier for recombinant toxins, it delivers PE38 to inhibit cellular protein synthesis and induce cytotoxicity in antigen-expressing cancer cells. Omburtamab can be used in research related to glioma, breast cancer, osteosarcoma and neuroblastoma .
loading...
    loading...
Cat. No.: HY-E70199
CAS No.: 9054-63-1
Synonyms: APN/CD13
Target:  

Aminopeptidase

Research Areas:  

Cardiovascular Disease

Aminopeptidase N (rat) (APN/CD13) is a Zn 2+-dependent membrane-bound exopeptidase that preferentially degrades proteins and peptides with N-terminal neutral amino acids. Aminopeptidase N (rat) is inhibited by angiotensin IV and participates in the regulation of angiotensin IV half-life in the rat striatum .
loading...
    loading...
Cat. No.: HY-P1764
CAS No.: 149146-12-3
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Secretoneurin, rat, a 33-amino acid polypeptide, is generated by proteolytic processing of secretogranin II (SgII). Secretoneurin, rat induces dopamine release in the rat striatum in vivo and in vitro, and it exerts a very strong chemotactic effect on monocytes and eosinophils but not on granulocytes .
loading...
    loading...
Cat. No.: HY-160959
CAS No.: 946074-35-7
Target:  

nAChR

Research Areas:  

Neurological Disease

AN317 is a selective agonist for α6β2-containing nicotinic acetylcholine receptor (nAChR) with Ki of 6.2 nM and 4.1 nM, for α6/α3β2β3 receptor and α4β2 receptor, respectively. AN317 induces dopamine release in the synaptosomes of the rat striatum, enhances dopaminergic neuronal activity in substantia nigra, and exhibits protective efficacy to rat neurons against dopamine neurotoxin MPP +. AN317 exhibits good pharmacokinetic characteristics in rats. AN317 penetrates the blood-brain barrier (BB) .
loading...
    loading...
Cat. No.: HY-106584
CAS No.: 89419-40-9
Synonyms: Clospipramine
Mosapramine (Clospipramine) is an orally active antipsychotic agent and one of the metabolites of Clocapramine (HY-B2073) after oral absorption. Mosapramine exerts its effects by specifically binding to striatal dopamine D2 receptors and frontal lobe 5-HT2 receptors, with a D2/5-HT2 receptor occupancy ratio of 7.4. Mosapramine induces typical neuropharmacological responses in rat brain regions, including extrapyramidal symptoms, hyperprolactinemia, increased salivation, constipation, and upregulated Fos protein expression. Mosapramine also features a reduced incidence of weight loss. Mosapramine is applicable to research related to schizophrenia .
loading...
    loading...
Cat. No.: HY-NP180
Progesterone/BSA is a conjugate of Progesterone (HY-N0437) and bovine serum albumin (BSA). Progesterone/BSA cannot penetrate the plasma membrane of human sperm, but still rapidly elevates intracellular free calcium and induces the acrosome reaction. Progesterone/BSA can also act as a probe to specifically bind to progesterone-binding proteins on the membrane of rat brain synaptosomes .
loading...
    loading...
Cat. No.: HY-P3800
CAS No.: 56104-22-4
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Endocrinology

[Glp5] Substance P (5-11) is an octapeptide. [Glp5] Substance P (5-11) is one of the main substance P fragments in rat central nervous system (CNS). [Glp5] Substance P (5-11) locally modulates dopamine release in rat striatum .
loading...
    loading...
Cat. No.: HY-B0884
CAS No.: 25905-77-5
Minaprine is a brain-penetrant monoamine oxidase inhibitor. Minaprine also weakly inhibits acetylcholinesterase (AChE) activity. Minaprine reduces intraneuronal dopamine metabolism, lowers striatal homovanillic acid and dihydroxyphenylacetic acid levels, and raises striatal 3-methoxytyramine and 5-hydroxytryptamine levels. Minaprine exhibits convulsant, antidepressant properties .
loading...
    loading...
Cat. No.: HY-12520
CAS No.: 67287-49-4
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease Cancer

SKF 38393 is a selective dopamine D1 receptor agonist. SKF 38393 activates the cAMP signaling pathway and promotes dopamine release in the developing rat striatum. SKF 38393 inhibits MCF-7 breast cancer cell proliferation (IC50=0.1 μM). SKF 38393 is promising for research of neurodevelopmental disorders, dopamine-related diseases (e.g., Parkinson’s, dopamine deficiency), and cancers .
loading...
    loading...
Cat. No.: HY-14197AR
CAS No.: 17780-75-5
Research Areas:  

Metabolic Disease

Clorgyline hydrochloride (Standard) is the analytical standard of Clorgyline hydrochloride. This product is intended for research and analytical applications. Clorgyline hydrochloride is an irreversible and selective inhibitor of monoamine oxidase A (MAO-A) that is used in scientific research, structurally related to Pargyline (HY-A0091A). Clorgyline hydrochloride has little effect on the amounts of conjugated dopamine (DA) present in superfusate of slices from rat striatum. Clorgyline hydrochloride contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
loading...
    loading...
Cat. No.: HY-19845A
CAS No.: 871351-61-0
Synonyms: ACR-325 hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Ordopidine hydrochloride is a modulator of dopamine receptor extracted from patent WO/2005/121087A1, compound example 2; exhibits an ED50 of 68 μmol/kg on increase of DOPAC in the rat striatum.
loading...
    loading...
Cat. No.: HY-113726
CAS No.: 102771-12-0
Synonyms: GYKI52322; EGIS-6775
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Nerisopam is an orally active gamma-aminobutyric acid (GABA) receptor agonist. Nerisopam is an anxiolytic and antipsychotic homophthalazine. Nerisopam induces rapid, intense expression of Fos-like immunoreactivity in the rostral, dorsomedial and lateral parts of the striatum in the rat .
loading...
    loading...
Cat. No.: HY-119409
CAS No.: 24558-01-8
Synonyms: Phacetoperane free base
Target:  

Dopamine Transporter

Research Areas:  

Neurological Disease

Levophacetoperane (Phacetoperane free base) competitively inhibits the uptake of norepinephrin and dopamine .
loading...
    loading...
Cat. No.: HY-114578
CAS No.: 104229-37-0
Research Areas:  

Neurological Disease

PD 118717 is a selective dopamine (DA) D-2 autoreceptor agonist. PD 118717 has significant affinity for 5-HT1A but not 5-HT1B and 5-HT2 receptors. PD 118717 is active in antagonizing the tau-Butyrolactone-induced accumulation of dopa in rat striatum and mesolimbic regions. PD 118717 exhibits an antipsychotic-like profile .
loading...
    loading...
Cat. No.: HY-171328
CAS No.: 1076189-55-3
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

RG-15 is the orally active antagonist for dopamine receptor that exhibits goof affinity to human D2 receptor and human D3 receptor with pKi of 8.23 and 10.49. RG-15 inhibits dopamine-stimulated [ 35S]GTPγS binding with IC50 of 21.2 nM (rat striatal membranes), 36.7 nM (mouse A9 cells expressing human D2L receptors) and 7.2 nM (CHO cells expressing human D3 receptors). RG-15 increases the turnover and biosynthesis of dopamine in mouse striatum and olfactory bulb, exhibiting antipsychotic activity .
loading...
    loading...
Cat. No.: HY-14835
CAS No.: 537034-22-3
Synonyms: SSR240600
Target:  

Others

Research Areas:  

Others

Burapitant (SSR240600) is a compound that modulates cholinergic transmission and regulates acetylcholine release in the limbic/prefrontal region of the rat striatum, with its effects being influenced by the interaction of 5-HT? and 5-HT? receptors.
loading...
    loading...